Showing 101-110 of 1692 results for "".
Niche No Longer: Bringing Sleep Medicine to the Forefront of Neurological Practice
https://practicalneurology.com/diseases-diagnoses/sleep/niche-no-longer-bringing-sleep-medicine-to-the-forefront-of-neurological-practice/30415/Emerging insights in the realm of sleep are shaping new understandings of neurological diseases.- Achieving Freedom From AEDs Without Compromising Controlhttps://practicalneurology.com/columns/practice-management/achieving-freedom-from-aeds-without-compromising-control/31393/Tapering Antiepileptic Drugs: Balancing Seizure Control and Quality of LifeIn the October 2005 issue of *Practical Neurology*, Dr. Christopher Skidmore explores whether epilepsy necessitates lifelong antiepileptic drug (AED) therapy. Highlighting the dual objectives of achieving seizure control whil
Management of Overactive Bladder and Urge Incontinence
https://practicalneurology.com/diseases-diagnoses/tbi/management-of-overactive-bladder-and-urge-incontinence/30632/An expert overview of the step-wise approach to management of this common and costly condition.- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn0607-epilepsy-pdf/31161/Managing Drug Interactions in Epilepsy Treatment: Key Considerations for Healthcare ProfessionalsEpilepsy, affecting over one percent of the population, often requires long-term or lifelong management with antiepileptic drugs (AEDs). While two-thirds of patients achieve seizure control with monother
Recent Advances in the Medical Treatment of Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/recent-advances-in-the-medical-treatment-of-epilepsy/30795/From agents in early clinical trials to relatively recent approvals, multiple treatments may improve the care of common and rare forms of epilepsy.Special Report: 2023 Neurology Drug & Device Approvals
https://practicalneurology.com/diseases-diagnoses/imaging-testing/special-report-2023-neurology-drug-device-approvals/32081/A quick reference for the drugs and devices for neurologic conditions that received approval from the Food and Drug Administration last year.- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn0907-dementia-pdf/31121/Anosognosia in Alzheimer’s Disease: Understanding Unawareness of Cognitive DeficitsAnosognosia, the lack of awareness of one’s own cognitive and functional impairments, is a significant challenge in managing Alzheimer’s Disease (AD). Research indicates that over half of AD patients exhibit partial o
- Using Botox to “Loosen” Spastic Muscleshttps://practicalneurology.com/diseases-diagnoses/neuromuscular/pn0807-botox-pdf/31132/Botulinum Toxin as an Effective Treatment for Post-Stroke SpasticityPost-stroke spasticity remains a significant challenge for approximately one-third of the 5.7 million stroke survivors in the United States, often leading to disabilities such as muscle weakness, incoordination, and altered muscle t
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1107epilepsy-pdf/31101/Febrile seizures are a prevalent neurological concern in pediatric populations, affecting approximately 4% of children in the United States. Typically occurring between one month and five years of age, with a peak incidence at 18 to 22 months, these seizures are triggered by febrile illnesses rather
- A Century of Alzheimer's: Progress and Pitfallshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn1106-100years-pdf/31244/Alzheimer’s disease (AD), first identified by Alois Alzheimer in 1906 through the examination of Auguste D.’s brain, has evolved into one of the most extensively studied neurological disorders. Despite over a century of research, AD remains challenging to predict, diagnose accurately in living patie